Alzheimer's Disease Clinical Trials in Phoenix

Showing 161-166 of 166 trials

Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

NCT00454870

The purpose of this study is to determine in an 8-week treatment study if MEM 3454 is a safe and effective treatment for patients with mild to moderate Alzheimer's disease.

Alzheimer's Disease

Memory Pharmaceuticals80 participantsStarted Feb 2007

Phoenix, Arizona, United States • Glendale, California, United States • Atlanta, Georgia, United States +4 more locations

COMPLETEDPhase 313 miles

ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)

NCT00231946

The study is designed to investigate the activity of the hormone drug leuprolide acetate in stabilizing cognitive function in mild-to-moderate AD patients.

Alzheimer's Disease

Voyager Pharmaceutical Corporation555 participantsStarted Sep 2005

Peoria, Arizona, United States • Tucson, Arizona, United States • Fresno, California, United States +56 more locations

Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)

Alzheimer's Disease Trials in Other Cities

Multicenter Trial of Prednisone in Alzheimer's Disease

A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex

Agitation in Alzheimer's Disease

Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease

Other Conditions in Phoenix